In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Acologix gets N. American, European rights to Toray's TRK-820

Executive Summary

Toray Industries has granted Acologix (focused on the development of therapeutics for bone and kidney diseases) an exclusive North American development and marketing license to TRK-820. The companies will co-develop the drug candidate in Europe, with Acologix getting the option to market it there.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • R+D and Marketing-Licensing
    • Includes Equity

Related Companies